Phasing-in RHD genotyping

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 5, 2014, Pages 585-588

  Flegel, Willy A ^a   Roseff, Susan D ^a   Tholpady, Ashok ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; RHO(D) ANTIGEN;

BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; FEMALE; GENETICS; GOOD LABORATORY PRACTICE; HUMAN; IMMUNOLOGICAL PROCEDURES; METHODOLOGY; PHENOTYPE; REVIEW; STANDARD; STATISTICS;

BLOOD TRANSFUSION; FEMALE; HUMANS; IMMUNOLOGIC TESTS; LABORATORY PROFICIENCY TESTING; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 84900479818     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/2013-0509-ED     Document Type: Review

References (22)

1. Sandler SG, Roseff SD, Domen RE, Shaz BH, Gottschall JL. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin. Arch Pathol Lab Med. 2014;138(5):620-625.
2. Carson TH. Standards for Blood Banks and Transfusion Services. 28th ed. Bethesda MD: American Association of Blood Banks; 2012.
3. Kennedy MS. Perinatal issues in transfusion practice. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, eds. AABB Technical Manual. 18th ed. Bethesda, MD: American Association of Blood Banks; 2012:637-650.
4. Sandler SG, Gottschall JL. Obstetrics and gynecology: ask the experts- postpartum Rh immunoprophylaxis. Washington, DC: The American College of Obstetricians and Gynecologists. http://journals.lww.com/greenjournal/Documents/ Dec2012-AtE-Sandler.pdf. Accessed October 17, 2013.
5. Wagner FF, Gassner C, M̈uller TH, Scḧonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999;93(1):385-393.
6. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood. 2000;95(8):2699-2708.
7. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006;13(6):476-483.
8. McGann H,Wenk RE. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology. 2010;26(1):27-29.
9. Sandler SG, Li W, Langeberg A, Landy HJ. New laboratory procedures and Rh blood type changes in a pregnant woman. Obstet Gynecol. 2012;119(2, pt 2): 426-428.
10. Sandler SG, Gottschall JL. Postpartum Rh immunoprophylaxis. ObstetGynecol. 2012;120(6):1428-1438.
11. Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implicationsfor anti-D alloimmunization and prevention. Transfusion. 2005;45(10):1554-1560.
12. Garratty G. Do we need to be more concerned about weak D antigens? Transfusion. 2005;45(10):1547-1551.
13. Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol. 2010;134(3):438-442.
14. Cruz BR, Chiba AK, Moritz E, Bordin JO. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med. 2012;22(2):84-89.
15. Moussa H, Tsochandaridis M, Chakroun T, et al. Molecular background of D-negative phenotype in the Tunisian population. Transfus Med. 2012;22(3):192-198.
16. Flegel WA, Denomme GA, Yazer MH. On the complexity of D antigen typing: a handy decision tree in the age of molecular blood group diagnostics. J Obstet Gynaecol Can. 2007;29(9):746-752.
17. FlegelWA,Wagner FF. Molecular genetics of RH. Vox Sang. 2000;78(suppl 2):109-115.
18. FlegelWA, von Zabern I, Doescher A, et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion. 2009;49(6):1059-1069.
19. Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies? Transfusion. 2011;51(12):2679-2685.
20. Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood. 2010;116(15):2836-2838.
21. Schmid P, von Z, I, Scharberg EA, Wagner FF, Flegel WA. Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD. Transfusion. 2010;50(1):267-269.
22. Flegel WA. The genetics of the Rhesus blood group system. Blood Transf. 2007;5(2):50-57.